Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,012
datasets available to search
ShareScore release 0.9.0
Dataset results
2,012 results for “Kinase”
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
ClinicalTrials.gov study NCT06151730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
ClinicalTrials.gov study NCT03194893. IPD Sharing: YES. Countries: 9. Publications: 0.
Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma
ClinicalTrials.gov study NCT01249066. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
ClinicalTrials.gov study NCT05218668. IPD Sharing: NO. Countries: 2. Publications: 0.
The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04018183. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing,
ClinicalTrials.gov study NCT05557045. IPD Sharing: NO. Countries: 1. Publications: 0.
Mechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure)
ClinicalTrials.gov study NCT05773391. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer
ClinicalTrials.gov study NCT01411410. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
ClinicalTrials.gov study NCT03287271. IPD Sharing: NO. Countries: 1. Publications: 0.
The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase
ClinicalTrials.gov study NCT02755337. IPD Sharing: NO. Countries: 1. Publications: 0.
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
ClinicalTrials.gov study NCT05971758. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
ClinicalTrials.gov study NCT03958565. IPD Sharing: YES. Countries: 1. Publications: 0.
A Retrospective Study of Subjects With Thymidine Kinase 2 Deficiency
ClinicalTrials.gov study NCT05017818. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation
ClinicalTrials.gov study NCT04691648. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Early Stereotactic Body Radiation Therapy to the Primary Tumor in Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03727867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in
ClinicalTrials.gov study NCT00974584. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00552227. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Changes in Positron Emissions Tomography (PET/CT) Scan as Predictors of Clinical Outcome in NSCLC Treated With EGFR Tyrosin Kinase Inhibitors (TKI)
ClinicalTrials.gov study NCT02043002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT02729298. IPD Sharing: NO. Countries: 1. Publications: 0.
Tyrosine Kinase Inhibitors In Metastatic Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT01163058. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.